cbdMD, Inc. (NYSEAMERICAN:YCBD) Short Interest Down 13.1% in June

cbdMD, Inc. (NYSEAMERICAN:YCBDGet Free Report) saw a large decline in short interest in the month of June. As of June 15th, there was short interest totalling 142,300 shares, a decline of 13.1% from the May 31st total of 163,700 shares. Approximately 4.5% of the shares of the company are sold short. Based on an average daily volume of 198,300 shares, the short-interest ratio is presently 0.7 days.

Institutional Investors Weigh In On cbdMD

A hedge fund recently raised its stake in cbdMD stock. AXS Investments LLC grew its stake in shares of cbdMD, Inc. (NYSEAMERICAN:YCBDFree Report) by 42.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 91,204 shares of the company’s stock after buying an additional 27,017 shares during the period. AXS Investments LLC owned 2.99% of cbdMD worth $95,000 at the end of the most recent reporting period. 7.18% of the stock is owned by institutional investors.

cbdMD Trading Up 2.1 %

NYSEAMERICAN YCBD opened at $0.59 on Friday. The firm has a market cap of $2.28 million, a PE ratio of -0.05 and a beta of 1.99. cbdMD has a one year low of $0.56 and a one year high of $1.73. The company has a current ratio of 1.07, a quick ratio of 0.61 and a debt-to-equity ratio of 0.88.

cbdMD (NYSEAMERICAN:YCBDGet Free Report) last announced its quarterly earnings data on Wednesday, May 15th. The company reported ($1.35) earnings per share (EPS) for the quarter. cbdMD had a negative net margin of 102.25% and a negative return on equity of 193.04%. The firm had revenue of $4.82 million during the quarter.

About cbdMD

(Get Free Report)

cbdMD, Inc produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, and sleep, focus, and calming aids.

Recommended Stories

Receive News & Ratings for cbdMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for cbdMD and related companies with MarketBeat.com's FREE daily email newsletter.